← Eichor
Condition: Bladder Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Bladder Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
Phase N/A · 1 location(s) · Lahey Clinic · NCT00872495Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05126472Image-Guided Gynecologic Brachytherapy
NA · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT02993900IMPACT OF DIALYSIS DURATION AND DIURESIS ON BLADDER CAPACITY AND COMPLIANCE IN END STAGE RENAL DISEASE PATIENTS AWAITING
Phase N/A · 1 location(s) · Sindh Institute of Urology and Transplantation · NCT07570771Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
NA · 8 location(s) · Tianjin Medical University Second Hospital · NCT07180212Akyva First In Human
NA · 2 location(s) · Iota Biosciences, Inc · NCT06956209A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
Phase N/A · 8 location(s) · Cedars-Sinai Medical Center · NCT03193541Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Phase N/A · 6 location(s) · University of Washington · NCT07225127Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2 · 3 location(s) · Tianjin Medical University Second Hospital · NCT07475403Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder
NA · 1 location(s) · Zhujiang Hospital · NCT03108196Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial
Phase N/A · 1 location(s) · OHSU Knight Cancer Institute · NCT07726602Diagnosing Vesicoureteric Reflux in Children by Direct Isotope Cystography and Contrast Enhanced Voiding Ultrasonography
NA · 1 location(s) · Turku University Hospital · NCT06138080Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study
NA · 1 location(s) · University of Aarhus · NCT07339761Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Hist
Phase 2 · 4 location(s) · Emory University · NCT05756569Study Comparing Transobturator Cystocele vs. Anterior Vaginal RepairS
NA · 8 location(s) · Charles University, Czech Republic · NCT05602246Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Phase 2/Phase 3 · 1 location(s) · Northwestern University · NCT05878951Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Pa
Phase 2 · 16 location(s) · Theralase® Technologies Inc. · NCT03945162Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
Phase 4 · 1 location(s) · Walter Reed National Military Medical Center · NCT04020510Sacituzumab Govitecan Plus EV in Metastatic UC
Phase 1/Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT04724018Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
Phase N/A · 1 location(s) · Origin Sciences · NCT05102110Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT
NA · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06241274Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
Phase 2 · 1 location(s) · Mayo Clinic · NCT07087860Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)
Phase 3 · 3 location(s) · Rajiv Gandhi Cancer Institute & Research Center, India · NCT06712420Chemoablation for Low-Grade Bladder Cancer
Phase 2 · 1 location(s) · Ekaterina Laukhtina · NCT07019220The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging
NA · 1 location(s) · RenJi Hospital · NCT06763354Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
NA · 2 location(s) · Johns Hopkins University · NCT05792722Measuring Surgical Recovery After Radical Cystectomy
Phase N/A · 11 location(s) · M.D. Anderson Cancer Center · NCT03193970Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT06025734Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
Phase N/A · 1 location(s) · University of Zurich · NCT07494864Laparoendoscopic Rendezvous for Concomitant Gall Bladder Stones and Common Bile Duct Stones
NA · 1 location(s) · Minia University · NCT07008170
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.